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Objective: In 2015, we conducted at 44 healthcare facilities (HCFs) and 21 nursing
homes (NHs) a 3-month bloodstream infection (BSI) survey, and a 1-day prevalence
study to determine the rate of carriage of methicillin-resistant Staphylococcus aureus
(MRSA) in 891 patients and 470 residents. We investigated the molecular characteristics
of the BSI-associated and colonizing MRSA isolates, and assessed cross-transmission
using double-locus sequence typing and pulsed-field gel electrophoresis protocol.
Results: The incidence of MRSA-BSI was 0.040/1000 patient-days (19 cases). The
prevalence of MRSA carriage was 4.2% in patients (n = 39) and 8.7% in residents
(n = 41) (p < 0.001). BSI-associated and colonizing isolates were similar: none were
PVL-positive; 86.9% belonged to clonal complexes 5 and 8; 93.9% were resistant to
fluoroquinolones. The qacA/B gene was carried by 15.8% of the BSI-associated isolates
[3/3 BSI cases in intensive care units (ICUs)], and 7.7% of the colonizing isolates in
HCFs. Probable resident-to-resident transmission was identified in four NHs.
Conclusion: Despite generally reassuring results, we identified two key concerns. First,
a worryingly high prevalence of the qacA/B gene in MRSA isolates. Antisepsis measures
being crucial to prevent healthcare-associated infections, our findings raise questions
about the potential risk associated with chlorhexidine use in qacA/B+ MRSA carriers,
particularly in ICUs. Second, NHs are a weak link in MRSA control. MRSA spread was
not controlled at several NHs; because of their frequent contact with the community,
conditions are favorable for these NHs to serve as reservoirs of USA300 clone for local
HCFs.
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INTRODUCTION
Methicillin-resistant Staphylococcus aureus (MRSA) infections
have long been associated with healthcare facilities (HCFs) and
remain a matter of concern, due to the morbidity and mortality
associated with the infections they cause (de Kraker et al., 2011).
Over the last 20 years, the adherence of healthcare workers to
infection control guidelines for patients with MRSA carriage
has improved. This approach has proved eﬀective, leading to
a marked decrease in the incidence of healthcare-associated
infections (HAIs) due to MRSA (Cooper et al., 2004; McGinigle
et al., 2008; Rolain et al., 2015).
However, the epidemiology of MRSA is changing, with
the worldwide spread of Panton-Valentine leukocidin (PVL)-
producing MRSA previously implicated only in infections in
patients with no history of healthcare (Boyce, 2008; Popovich
et al., 2008). The spread of the ST8-USA300 clone is a matter of
particular concern. These MRSA isolates are increasingly being
implicated in HAIs (Tenover and Goering, 2009). In France,
infections associated with PVL-producing MRSA remain rare
(Robert et al., 2011). However, two clusters of ST8-USA300
infections were recently described, one in a rehabilitation care
center (Fournier, 2013) and the other in a residential home (Haut
Conseil de la Santé Publique, 2014).
We investigated epidemiological changes in the large “Centre
Val de Loire” region (2.6 million inhabitants), assessing MRSA
infection and colonization in the elderly, by conducting
a multicenter study. We conducted a 3-month survey of
bloodstream infections (BSI) associated with MRSA, and a
1-day prevalence study of MRSA carriage in patients and
residents. We studied the molecular characteristics of the
BSI-associated and colonizing MRSA isolates, and assessed
cross-transmission within institutions using molecular typing
tools. In addition, chlorhexidine resistance in MRSA being an
emerging threat (Edgeworth, 2011), the MRSA isolates were
screened for the presence of the qacA/B gene, i.e., the genetic
determinant for eﬄux-mediated resistance to chlorhexidine
(Poole, 2005).
MATERIALS AND METHODS
Survey of Bloodstream Infection
A 3-month survey of all cases of BSI was conducted at 47
HCFs (45 hospitals and two home hospitalization centers) and
nine independent nursing homes (NHs) between January 1 and
March 31 2015. These institutions had a total of 7,381 short-
stay beds, 2,187 rehabilitation care beds and 8,549 long-stay beds.
The survey covered 473,600 patient-days (PDs) in short-stay
units, 134,428 PDs in rehabilitation care units and 70,966 PDs in
long-stay units.
The methods used and the design of this study have
been reported elsewhere (van der Mee-Marquet et al., 2007).
Brieﬂy, BSI was deﬁned as a positive blood culture from
a patient with clinical or laboratory evidence of infection.
The variables reported included patient age and sex, origin
of the BSI and occurrence of death within 7 days of BSI
diagnosis. All S. aureus isolates from BSI cases were sent
to the central laboratory for extensive study. Identiﬁcation
was conﬁrmed by MALDI-TOF MS (bioMérieux, France).
Antimicrobial drug susceptibility testing was performed by the
agar disk diﬀusion method (Comité de l’Antibiogramme de
la Société Française de Microbiologie, 2015). The antibiotics
tested were penicillin G, oxacillin, erythromycin, lincomycin,
pristinamycin, tetracycline, kanamycin, tobramycin, gentamicin,
rifampin, fusidic acid, fosfomycin, peﬂoxacin and cotrimoxazole.
Vancomycin, teicoplanin and mupirocin Minimum Inhibitory
Concentration values were determined using E-test method
(bioMérieux, France). PCR assays were used to conﬁrm the
presence of the mecA gene (Cuny et al., 2011) and to detect
the lukS-PV and lukF-PV genes (Jarraud et al., 2002) and the
genetic determinant for chlorhexidine resistance qacA/B (Fritz
et al., 2013). MRSA isolates were typed using pulsed-ﬁeld gel
electrophoresis protocol (Murchan et al., 2003), and double-locus
sequence typing (DLST) (Basset et al., 2010). DLST-types were
assigned according to the DLST database (www.DLST.org). Using
eBURST algorithm, the relatedness between isolates was deﬁned
by clustering all DLST-types sharing one of the two alleles.
Carriage Study
The study was conducted at the 56 institutions participating in
the BSI study. The HCFs had medical, surgical and rehabilitation
care units, and at least one NH unit. For the 45 HCFs, we ﬁrst
selected one unit at random. We then selected 30 individuals
from this unit at random, for participation in the study. We
selected 30 individuals at random from each of the independent
NHs and home hospitalization centers. All the patients and
residents present in the institutions between January and March
2015 were eligible for recruitment. They (or their relatives) were
approached individually and asked for consent to access their
medical records and to culture a sample to test for S. aureus.
The 1-day point-prevalence study was carried out between
January 1 and March 31 2015. Each patient or resident was
included only once. Microbiological samples were collected from
all the individuals included. Patients and residents were screened
for S. aureus carriage by nasal swabbing (both nostrils). The swabs
were placed in 0.5 ml of sterile water and 0.1 ml of the resulting
suspension was streaked onto a Chapman selective agar plate
(bioMérieux, France). The plates were incubated for 48 h at 35◦C.
The identiﬁcation and molecular characterization of S. aureus
and MRSA isolates were as described for the BSI study.
Data were collected on a standardized questionnaire, for
all the individuals enrolled in the study. They included
demographic data (age and sex), physical disability and
signiﬁcant comorbidities, and various risk factors for MRSA
carriage (hospitalization and antibiotic use in the month
preceding inclusion in the study).
Univariate analyses were carried out with χ2 or Fisher’s exact
tests, as appropriate, for categorical variables and Student’s t-test
or Kruskall–Wallis test for continuous variables. All statistical
tests were two-tailed. We considered p-values <0.05 to be
statistically signiﬁcant. We used EpiInfo version 6 software
and Stata software version 10 (StataCorp., USA) for statistical
analysis.
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Confidentiality and Ethical Aspects
The study was carried out in accordance with French
recommendations for the prevention of infection in healthcare.
Ethical approval was obtained at the national level, from
the Réseau Alerte Investigation Surveillance des Infections
Nosocomiales (RAISIN). The study was managed jointly with
the directors of the HCFs and NHs, the hygiene nurses and the
physicians responsible for caring for the patients/residents, and
the regional infection control team.
RESULTS
BSI Study
Epidemiology
Nineteen cases of BSI due to MRSA were identiﬁed, 12 in male
patients and seven in female patients hospitalized in short-stay
units, including three in intensive care units (ICUs). This resulted
in an incidence rate of 0.040/1,000 PDs. The BSI was associated
with endocarditis (n = 1), infections of the skin (n = 5), lungs
(n = 4), the urinary tract (n = 3), a surgical site (n = 2) or an
intravenous device (n = 4). Most of the patients had a recent
history of hospitalization (63.2%), and of antibiotic treatment
(42.1%); one patient lived in a NH (5.3%). The early mortality
rate was 21.0%.
Molecular Characteristics of the BSI Isolates
The PVL gene was not detected in the 19 isolates studied. All
but one of the MRSA isolates were resistant to ﬂuoroquinolones
(94.7%) (Supplementary Table S1); 12 were resistant only to
methicillin and ﬂuoroquinolones (63.2%). Eburst clustering
revealed two major clusters: one comprising 9 (47.5%) isolates
from clonal complex (CC) 5 and the other containing 8
isolates from CC8 (42.1%) (Figure 1). The qacA/B gene was
detected in three isolates (15.8%) recovered from the three
patients hospitalized in diﬀerent ICUs (Supplementary Table S1,
Figure 1). One had a BSI of surgical origin, and the other two
had BSI of pulmonary origin, developing during the course of
mechanical ventilation. For these two cases, chlorhexidine mouth
washes were carried out daily during hospitalization.
Carriage Study
Population Characteristics
Sixty-ﬁve units participated in the study (Table 1); 921 patients
and 470 residents were enrolled in the study: 819 women (58.9%)
and 572 men (41.1%). The population was elderly (median age:
82 years) and had a poor health status, with 40.3% of individuals
having a McCabe index of 1 or 2 (fatal illness likely to occur
within the next 5 years). Cancer and immunodepression were
reported in 10.4 and 8.1% of the study subjects, respectively.
A recent history of urinary catheterization or of the insertion
of an intravenous device was reported for 4.9 and 14.7% of
the subjects studied, respectively. In addition, 14.4% of the
individuals had recently been treated with antibiotics, and, 13.6%
presented signs of infection on the day of the study. The
clinical characteristics diﬀered signiﬁcantly between patients and
residents. The very elderly population of residents had a better
health status, with signiﬁcantly fewer comorbid conditions than
the population of patients (Table 1). Among patients, those
hospitalized in surgical units were younger (p < 0.001) and had
a better health status than those from medical and rehabilitation
care units.
MRSA Carriage
Staphylococcus aureus carriage was found in 213 patients (23.1%)
and 130 residents (27.6%); 39 patients (4.2%) and 41 residents
(8.7%) were found to be MRSA carriers. The carriage rate was
between 0 and 25.0%, depending on the unit considered, and
was higher in residents than in patients (p < 0.001) (Table 2).
A carriage rate >10.0% was observed in 15.9% of the HCF
units and in 42.9% of the NH units (p < 0.018). Among
patients, the MRSA carriage rate was lower in surgical units
(p = 0.005). Twelve of the 80 MRSA carriers (15.0%) presented
signs of infection on the day of the study, but staphylococcal
infection was unlikely in all the cases. MRSA carriers were
older than the patients not carrying MRSA (p = 0.003) and
they also had a poorer health status: MRSA carriers were more
likely to have a McCabe index of 1 or 2 (p = 0.017), cancer
(p = 0.037) or an infection (p = 0.030) (Table 2). Among
residents, MRSA colonization was associated with poorer health
status (p = 0.022) and recent antibiotic treatment (p = 0.013)
(Table 2). The residents and patients did not diﬀer in terms of
clinical characteristics, except for median age (p = 0.006).
Molecular Characteristics of Colonizing MRSA
Isolates
The PVL gene was not detected in the 80 isolates studied.
Most of the 80 isolates were resistant to ﬂuoroquinolones
(93.7%; Supplementary Table S1). Fifty-one isolates (63.8%) were
resistant only to methicillin and ﬂuoroquinolones. DLST of the
80 isolates identiﬁed 34 DLST-types (Figure 1). Like the BSI
isolates, most colonizing isolates formed two major clusters,
one comprising 35 (43.7%) isolates from CC5 and the other
containing 34 isolates from CC8 (42.5%). The isolates colonizing
residents were associated with CC5 whereas those from patients
were associated with CC8 (p = 0.044). The qacA/B gene was
detected in three of the 39 isolates recovered from patients (7.7%)
(Supplementary Table S1, Figure 1); high level of resistance to
mupirocin (MIC value > 1024 mg/L) was observed in one of
these 39 isolates (2.6%) (Chaves et al., 2004). Isolates carrying
the qacA/B gene or mupirocin resistant were not recovered from
residents.
Spread of MRSA Within Institutions
In 12 cases, two or more isolates of the same DLST-type were
recovered from individuals from the same unit (Supplementary
Table S2). In four NH units, the isolates with similar DLST-types
also yielded similar PFGE patterns, suggesting an epidemiological
link between the isolates and cross-transmission within the NH.
The rate of MRSA carriage at these four NH units exceeded
11.0%. Separation of the 65 participating units into two groups
on the basis of carriage rate (below or above 10%) revealed an
association between possible cross-transmission and the group of
units with the highest carriage rates (p = 0.003).
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FIGURE 1 | Double locus sequence typing (DLST) single locus variant (SLV) clustering using eBurst on the 19 BSI-associated and 80 colonizing
MRSA isolates. Each circle represents one DLST-type and the number of the squares reflects the frequency of that type among colonizing (in blue) or
BSI-associated isolates (in red). Each green halo indicates possible epidemiologically related isolates and black halo indicates isolates carrying qacA/B gene. Linked
DLST-type differ at one of the two loci (clfB or spa).
DISCUSSION
Outside of the context of PVL-producing MRSA spread, data
concerning MRSA in elderly are scarce. We report a large-scale
multicenter study of MRSA BSI and carriage in elderly people
and provide insight into the current epidemiology of MRSA. Our
ﬁndings were generally reassuring.
Consistent with results of other studies (March et al., 2009;
Köck et al., 2010; Bellini et al., 2015), we found a low incidence
of MRSA-BSI in our region, an overall MRSA carriage rate of
4.2% in patients and 8.7% in residents, and a signiﬁcant link
between MRSA BSI or carriage and very old individuals with
numerous comorbid conditions, recent antibiotic exposure and
infection.
Concordant with previous studies, colonizing and infecting
isolates were genetically similar (Robinson and Enright, 2003;
Safdar and Bradley, 2008), and the isolates were equally
distributed among the major pandemic CCs CC5 and CC8 (Eko
et al., 2015). MRSA belonging to CC8 were mostly resistant
to ﬂuoroquinolones, erythromycin and aminoglycosides, while
most of isolates of CC5 were only resistant to ﬂuoroquinolones.
DLST analysis indicated wide heterogeneity among the studied
isolates, apart from a particular clone characterized by a unique
DLST-type (i.e., 42–163) and clustering one third of the MRSA
isolates recovered from colonized and infected patients/residents
hospitalized into highly diverse HCIs and NHs. These ﬁndings
suggest a successful clone spreading into our region.
We detected no colonizing MRSA isolates from the USA300
clone in the nasal ﬂora of the 1391 subjects enrolled. Despite
the limitations of our study design, such as the use of a
single nasal screening (McKinnell et al., 2013; Warnke et al.,
2014), our ﬁndings suggest that the spread of this clone has
not yet signiﬁcantly aﬀected the institutions in our region,
whereas clusters of infections associated with this clone have
recently been detected in France (Fournier, 2013; Haut Conseil
de la Santé Publique, 2014). However, we identiﬁed two key
concerns.
A Worryingly High Prevalence of the
qacA/B Gene in MRSA Isolates
The application of “search and isolate” or “search and destroy”
policies for MRSA carriers in ICUs, and the isolation of
patients infected with MRSA in all HCFs have resulted in
a decrease in the incidence of infections caused by MRSA
(McDanel et al., 2013). In this context, chlorhexidine is
increasingly used, especially as an antiseptic for skin and mucosal
membranes in HCFs, and for daily mouth wash in ICUs
(Milstone et al., 2008; Batra et al., 2010). Bacterial survival
following exposure to antiseptics has been recognized and
mechanisms conferring decreased susceptibility to antiseptics
have been identiﬁed (Harbarth et al., 2014). Recent studies
have described unintended consequences following the use of
chlorhexidine. First, the presence of the qacA/B gene has been
associated with unsuccessful decolonization during an ICU-
based topical chlorhexidine intervention (Lee et al., 2011);
second, the prevalence of reduced chlorhexidine susceptibility
has been shown to be high in organisms causing central
line-associated BSIs in ICUs in which patients are bathed
daily with chlorhexidine (Suwantarat et al., 2014); and third,
a MRSA isolate that carried the qacA/B gene and had
chlorhexidine MBC threefold higher compared with other
strains circulating on the unit, was selected following the
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TABLE 1 | Demographic, clinical characteristics and MRSA carriage of the 921 patients and 470 residents enrolled in the MRSA carriage study.
Healthcare facilities
medical unit
Surgical unit Rehab.1 Other units2 Nursing homes
Participating units 11 9 20 4 21
Patients/residents 354 280 794 229 1276
Patients/residents enrolled 206 185 452 78 470
Median age in years (gender) 85 (F)
82 (M)
73 (F)
69 (M)
82 (F)
75 (M)
64 (F)
69 (M)
88 (F)
83 (M)
McCabe index 1–2 (%) 51.6 13.0 37.1 68.9 41.9
Cancer (%) 13.2 4.4 13.6 19.5 7.1
Immunodepression (%) 9.7 2.2 10.5 37.7 2.6
Recent history of
urinary catheterization (%)
10.2 7.1 4.5 10.7 1.5
Intravenous device use (%) 36.4 38.6 6.4 14.7 3.6
Antibiotic treatment (%) 43.2 14.6 13.3 8.0 5.1
Signs of infection on the day of the
study (%)
41.0 10.4 12.6 4.0 5.5
Staphylococcus aureus carriers (%) 41 (19.9) 44 (23.8) 108 (23.9) 20 (25.6) 130 (25.7)
MSSA carriers (%) 30 (14.6) 43 (23.2) 85 (18.8) 16 (20.5) 89 (18.9)
MRSA carriers (%) 11 (5.3) 1 (0.5) 23 (5.1) 4 (5.1) 41 (8.7)
1Rehabilitation unit. 2One dialysis unit, two home hospitalization centers, one psychiatry unit.
TABLE 2 | Characteristics of the 921 patients and 470 residents enrolled in the MRSA carriage study, by MRSA carriage status.
Healthcare facilities MRSA carriers MSSA carriers S.aureus non-carriers MRSA non-carriers p∗
Number of patients 39 174 708 882
Median age (years) 83 76 79 79 0.034
McCabe index 1–2 (%) 59.0 38.5 34.2 38.6 0.017
Cancer (%) 23.1 11.5 11.4 11.6 0.037
Immunodepression (%) 18.4 10.3 10.4 10.6
Recent history of
urinary catheterization (%)
10.2 4.0 7.1 6.5
Intravenous device use (%) 25.6 23.0 22.3 20.0
Antibiotic treatment (%) 28.2 12.1 19.9 18.9
Signs of infection on the day of
the study (%)
30.8 10.3 18.4 17.2 0.030
Nursing homes
Number of residents 41 89 340 429
Median age (years) 87 88 86 86
McCabe index 1–2 (%) 51.2 35.9 36.8 33.5 0.022
Cancer (%) 7.5 6.7 7.1 7.1
Immunodepression (%) 7.5 3.4 1.8 2.1 0.075
Recent history of
urinary catheterization (%)
4.9 2.2 0.1 1.2
Intravenous device use (%) 0 3.4 4.1 3.4
Antibiotic treatment (%) 14.6 1.1 5.0 4.2 0.013
Signs of infection on the day of
the study (%)
12.2 1.1 5.9 4.9 0.066
*Comparison of MRSA carriers and MRSA non-carriers; only significant p-values are shown.
introduction of a chlorhexidine-based decolonization regimen
(Batra et al., 2010). In addition, several studies have underlined
how the presence of qacA/B gene may confer a selective
advantage in the presence of chlorhexidine use (Ho and
Branley, 2012; Otter et al., 2013). Before this study, data
about the presence of the qacA/B gene in MRSA isolates
colonizing/infecting elderly French people were not available.
The high prevalence of the qacA/B gene in BSI isolates
(3/3 cases in ICUs), and in isolates into the microbiota of
patients is worrisome. These aspects require further prospective
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investigation and continued surveillance. To date, there is a lack
of a standard deﬁnition of resistance to antiseptics, absence of
standardized methods of detection, and no systematic method
for measuring the clinical impact of reduced susceptibility to
antiseptics (Harbarth et al., 2014). Our ﬁndings raise questions
about the relationship between the carriage of chlorhexidine
eﬄux-mediated resistance genes and reduced chlorhexidine
susceptibility, and about the potential risk associated with
chlorhexidine use in qacA/B+ MRSA carriers, particularly
in ICUs. Reduced susceptibility to antiseptics could become
an increasing problem; its clinical impact needs further
research.
NHs Remain a Weak Link in MRSA
Control
The relatively low rates of MRSA carriage masked diﬀerent
situations: rates ranged from 0 to 25.0% in participating units,
whereas the prevalence of comorbid conditions and risk factors
were similar for all units and could not account for the
observed diﬀerences. The spread of MRSA was controlled in
most participating NH units. Whereas this occurred without the
application of a “search and isolate” strategy for MRSA carriers in
these NHs. This indirectly conﬁrm that in NHs, where invasive
care procedures are rare and generally concern residents in
reasonable health, the application of standard precautions during
care procedures and the respect of basic hand hygiene measures
by all staﬀ and, as far as possible, by the residents, prevent the
resident-to-resident transmission of MRSA.
Colonizing isolates carried by more than one resident yielded
similar DLST types in several NHs, suggestive of intra-NH
resident-to-resident transmission. However, the design of our
study does not allow to various other possibilities to be excluded,
for example, importation from acute care settings that cared
the many of the residents. In HCFs, the colonizing isolates
were genetically diverse, probably reﬂecting better respect of
hygiene rules in HCFs, whereas standard precautions remain
inconsistently applied in NHs (Cochard et al., 2014). In NHs,
the risk of infection is low and infections are rare. Consequently,
the care staﬀ does not apply hygiene practices rigorously
when caring for the residents and between cares acts for
diﬀerent residents, and MRSA may spread on their hands. In
addition, unlike patients conﬁned to bed in HCFs, residents
frequently interact with other residents, thereby spreadingMRSA
via their hands if their hand hygiene is not of quality. In
situations in which residents are repeatedly hospitalized, the
NHs may serve as reservoirs of MRSA for the local HCFs.
Because of their frequent contact with the community in which
the USA300 clone is spreading, the NHs could serve as a
site for the spread of this troublesome clone in the near
future in the absence of signiﬁcant improvements in preventive
measures.
This argues for continual eﬀorts to prevent the spread of
MRSA in NHs. Education is required to promote hand hygiene,
the appropriate use of gloves and the restriction of glove use
when not required. Point-prevalence studies of carriage should
be conducted regularly in NHs, and MRSA carriage rates should
be used as a quality indicator to focus the attention of healthcare
workers on the spread of MRSA.
AUTHOR CONTRIBUTIONS
All authors listed have made substantial contribution to the work
(CR, GC,MD, and SDS: acquisition of data; NVDM,DB, andHG:
data analysis and interpretation of data, NVDM, and RQ: study
design and drafting the paper), and approved it for publication.
FUNDING
This work was supported by the Agence Régionale de Santé of
the Centre Val de Loire region, and Tours University Hospital,
France.
ACKNOWLEDGMENTS
Participating physicians and nurses from the Infection Control
RegionalWorking Group of the Réseau des Hygiénistes du Centre:
P. Amirault, Vierzon; Y. Guimard, M.-N. Bachelier, Bourges; D.
Guenot, P.Harriau, Saint AmandMontrond; O. Lehiani, Vierzon,
Bourges and St Amand Montrond; I. Chazalette, O. Laurent,
Bourges; F. Tiako-Kameni, M.-J. Meyer, F. Guinard, Saint
Doulchard; Y. Bottine, A. Lepineux-Da Rocha, Saint Amand
Montrond; M. D. Nguyen, M. Boucher, L. Bret, Chateaudun; M.
Hamrouni, O. Zamﬁr, Chartres; E. Uzureau, Nogent le Rotrou; F.
Grobost, La Ferté Bernard; G. Petit, Chartres, Nogent le Rotrou;
S. Soubras, M. Morvan, La Chatre; M.-C. Des Garets, Vierzon;
N. Bouquet, V. Michel, Le Blanc; C. Burucoa, Poitiers; M. Hira,
D. Ratovohery, C. Decreux, G. Courouble, Chateauroux; Y.
Creton, Valencay; M. Longeaud, Levroux; N. Reginaud, Valencay,
Levroux; J.-P. Chevanne, M. Hénault, Chabris; A. Pierquin,
Contres; C. Etienne, Tours; A. Holstein, E. Haguenoer, Chambray
les Tours; P. Plichon, B. Patrigeon, Loches; O. Adibat, Ligueil;
B. Mankikian, V. salaün, Tours; B. Cattier, H. Leloup, Amboise;
R. Quentin, V. Morange, L. Méréghetti, A.-S. Valentin, Tours;
C. Goulet, Chinon; S. Liébault, Saumur; N. Fourmaux-Schmitt,
Saint Benoit La Forêt; F. Deperrois, Chinon, Saint Benoit La
Forêt; S. Watt, Chambray les Tours; F. Bousquet, S. Huault,
Tours; S. Kubas, L. Lepareux, Ballan Miré; C. De Gialully, Tours;
M. Picard, Chambray les Tours; J. Kamga, I. Cloarec, Sainte
Maure de Touraine; J.-P. Buraschi, Saint Avertin; P. Asquier,
S. Guittet, Chambray les Tours; P. De Calbiac, Romorantin,
Saint Aignan sur Cher; C. Hombrouck-Alet, Romorantin, Blois;
M. Lang, E. Coignaud-Beauﬁls, V. Descarpentries, N. Girard,
Blois; S. Jouanneau, Saint Aignan sur Cher; G. Doliges, V.
Chevereau, T. Gourdet, La Chaussée Saint Victor; E. Cabrol,
La Chaussée Saint Victor; M. Moulin, Chailles; I. Lafaille,
Saint Dye sur Loire; S. Touquet-Garnaud, M. Demasure, D.M.
Poisson, Orléans; F. Lagarde, R. Fournier-Hoock, E. Brème,
N. Nicola, Amilly Montargis; B. Benaicha, M. Prévost-Houssar,
Pithiviers; J.-M. Laurelli, B. Rousseau, G. Delaporte, Gien; G.
Petrescu, V. Gache, Briare; D. Gauthier, F. Zekrini, Sully sur
Loire; A. Desjardin, Nevers; P. De Person, Sully sur Loire;
Frontiers in Microbiology | www.frontiersin.org 6 January 2016 | Volume 7 | Article 31
Rondeau et al. Current Epidemiology of MRSA in French Elderly
R. Andriamiarisoa, C. Lefort, Neuville aux Bois; W. Lakhal,
Fleury les Aubrais; P. Bernabe, P. Renaud, Lorris; D. Montoy,
Bourges; M. Salles, Henrichemont; A. Barei Moniri, M. Collonge,
Vernouillet; M. Petit, F. Chollon, Chateaudun; E. Koﬃ Kan,
La Chatre; C. Dubois, V. Perrier, Pouligny Notre dame; M.-C.
Boudarene, S. Rossard, La membrolle sur Choisille; A. Lascaud,
A. Couturier, Saint Christophe sur le Nais; D. Pinault, C.
Champagne, Tours; A. Favre, B. Héraclide, Tours; J.-M. Paul;
Romorantin; T. Ali Haimoud, C. Bonny, Lamotte Beuvron; M.
Aubault, M.-E. Viginier, Vendome; F. Tillie, D. Budes, Selles sur
Cher; S. Maintier, A. Lemore, Montoire sur le Loir; B. Baudron,
Montoire sur le Loir; H. Naceur, Montoire sur le Loir; I. Denuc,
Orléans; M.-C. Pocquet, Pithiviers; M. Audibert, Gien.
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found
online at: http://journal.frontiersin.org/article/10.3389/fmicb.
2016.00031
REFERENCES
Basset, P., Senn, L., Prod’hom, G., Bille, J., Francioli, P., Zanetti, G.,
et al. (2010). Usefulness of double locus sequence typing (DLST) for
regional and international epidemiological surveillance of using methicillin-
resistant Staphylococcus aureus. Clin. Microbiol. Infect. 16, 1289–1296. doi:
10.1111/j.1469-0691.2009.03070.x
Batra, R., Cooper, B. S., Whiteley, C., Patel, A. K., Wyncoll, D., Edgeworth, J. D.,
et al. (2010). Eﬃcacy and militation of a chlorhexidine-based decolonization
strategy in preventing transmission of methicillin-reistant Staphylococcus
aureus in an intensive care unit. Clin. Infect. Dis. 50, 210–217. doi:
10.1086/648717
Bellini, C., Petignat, C., Masserey, E., Büla, C., Burnand, B., Rousson, V., et al.
(2015). Universal screening and decolonization for control of MRSA in nursing
homes: a cluster randomized controlled study. Infect. Control Hosp. Epidemiol.
36, 401–408. doi: 10.1017/ice.2014.74
Boyce, J. M. (2008). Community-associated methicillin-resistant Staphylococcus
aureus as a cause of health care-associated infection. Clin. Infect. Dis. 46,
795–798. doi: 10.1086/528717
Chaves, F., Garcia-Martinez, J., de Miguel, S., and Otero, J. R. (2004).
Molecular characterization of resistance to mupirocin in methicillin-
susceptible and – resistant isolates of Staphylococcus aureus from nasal
samples. J. Clin. Microbiol. 42, 822–824. doi: 10.1128/JCM.42.2.822-82
4.2004
Cochard, H., Aubier, B., Quentin, R., and van der Mee-Marquet, N. (2014).
Extended-spectrum β-lactamase-producing Enterobacteriaceae in French
nursing homes: an association between high carriage rate among residents,
environmental contamination, poor conformity with good hygiene practice,
and putative resident-to-resident transmission. Infect. Control Hosp. Epidemiol.
35, 384–389. doi: 10.1086/675599
Comité de l’Antibiogramme de la Société Française de Microbiologie (2015).
Communiqué 2015. Paris: SF Med. Available at: http://www.sfm-microbiologie.
org
Cooper, B. S., Stone, S. P., Kibbler, C. C., Cookson, B. D., Roberts, J. A.,
Medley, G. F., et al. (2004). Isolation measures in the hospital management of
methicillin-resistant Staphylococcus aureus: systematic review of the literature.
Br. Med. J. 329, 533–539. doi: 10.1136/bmj.329.7465.533
Cuny, C., Layer, F., Strommenger, B., and Witte, W. (2011). Rare occurrence
of methicillin-resistant Staphylococcus aureus CC130 with a novel
mecA homologue in humans in Germany. PLoS ONE 6:e24360. doi:
10.1371/journal.pone.0024360
de Kraker, M. E., Davey, P. G., and Grundmann, H. (2011). Mortality and
hospital stay associated with resistant Staphylococcus aureus and Escherichia coli
bacteremia: estimating the burden of antibiotic resistance in Europe. PLoSMed.
8:e1001104. doi: 10.1371/journal.pmed.1001104
Edgeworth, J. D. (2011). Has decolonization played a central role in the decline
in UK methicillin-resistant Staphylococcus aureus transmission? A focus on
evidence from intensive care. J. Antimicrob. Chemother. 66(Suppl.2), ii41-ii-47.
doi: 10.1093/jac/dkq325
Eko, K. E., Forshey, B. M., Carrel, M., Schweizer, M. L., Perencevich, E. N.,
and Smith, T. C. (2015). Molecular characterization of methicillin-resistant
Staphylococcus aureus (MRSA) nasal colonization and infection isolates in
a veterans aﬀairs hospital. Antimicrob. Resist. Infect. Control 4:10. doi:
10.1186/s13756-015-0048-5
Fournier, S. (2013). Epidémie à Staphylococcus aureus Resistant à la Méticilline
(SARM) Exprimant la Leucocodine de Panton Valentine Dans un Service de
Soins de Suite et de Réadaptation. La Lettre du Signalement des Infections
Nosocomiales. Available at: http://www.invs.sante.fr/esin [accessed Décembre 9,
2013].
Fritz, S. A., Hogan, P. G., Camins, B. C., Ainsworth, A. J., Patrick, C.,
Martin, M. S., et al. (2013). Mupirocin and chlorhexidine resistance in
Staphylococcus aureus in patients with community-onset skin and soft tissue
infections. Antimicrob. Agents Chemother. 57, 559–568. doi: 10.1128/AAC.01
633-12
Harbarth, S., Tuan Soh, S., Horner, C., and Wilcox, M. H. (2014). Is
reduced susceptibility to disinfectants and antiseptics a risk in healthcare
settings? A point/counterpoint review. J. Hosp. Infect. 87, 194–202. doi:
10.1016/j.jhin.2014.04.012
Haut Conseil de la Santé Publique (2014). Conduite à Tenir Lors d’Épisodes de Cas
groupés d’Infections Cutanées Suppuratives Liées aux Souches de SARMCo. Paris:
Haut Conseil de la Santé Publique.
Ho, J., and Branley, J. (2012). Prevalence of antiseptic resistance genes qacA/B
and speciﬁc sequence types of methicillin-reistant Staphylococcus aureus in
the era of hand-hygiene. J. Antimicrob. Chemother. 67, 1549–1550. doi:
10.1093/jac/dks035
Jarraud, S., Mougel, C., Thioulouse, J., Lina, G., Meugnier, H., Forey, F., et al.
(2002). Relationships between Staphylococcus aureus genetic background,
virulence factors, agr groups (alleles), and human disease. Infect. Immun. 70,
631–641. doi: 10.1128/IAI.70.2.631-641.2002
Köck, R., Becker, K., Cookson, B., van Gemert-Pijnen, J. E., Harbarth, S.,
Kluytmans, J., et al. (2010). Methicillin-Resistant Staphylococcus Aureus
(MRSA): Burden of Disease and Control Challenges in Europe. Eurosurv
2010. Available at: http://www.eurosurveillance.org/ViewArticle.aspx?
ArticleId=19688
Lee, A. S., Macedo-Vinas, M., François, P., Renzi, G., Schrenzel, J., Vernaz, N., et al.
(2011). Impact of combined low-level mupirocin and genotypic chlorhexidine
resistance on persistent methicilline-resistant Staphylococcus aureus carriage
after decolonization therapy: a case-control study. Clin. Infect. Dis. 52, 1422–
1430. doi: 10.1093/cid/cir233
March, A., Aschbacher, R., Dhanji, H., Livermore, D. M., Böttcher, A., Sleghel, F.,
et al. (2009). Colonization of residents and staﬀ of a long-term-care
facility and adjacent acute-care hospital geriatric unit by multiresistant
bacteria. Clin. Microbiol. Infect. 16, 934–944. doi: 10.1111/j.1469-0691.2009.0
3024.x
McDanel, J. S., Murphy, C. R., Diekema, D. J., Quan, V., Kim, D. S.,
Peterson, E. M., et al. (2013). Chlorhexidine and mupirocin susceptibilities
of methicillin-resistant Staphylococcus aureus from colonized nursing home
residents. Antimicrob. Agents Chemother. 57, 552–558. doi: 10.1128/AAC.01
623-12
McGinigle, K. L., Gourlay, M. L., and Buchanan, I. B. (2008). The use of active
surveillance cultures in adult intensive care units to reduce methicillin-resistant
Staphylococcus aureus-related morbidity, mortality and costs: a systematic
review. Clin. Infect. Dis. 46, 1717–1725. doi: 10.1086/587901
McKinnell, J. A., Huang, S. S., Eells, S. J., and Miller, L. G. (2013). Quantifying
the impact of extranasal testing of body sites for methicillin-resistant
Staphylococcus aureus colonization at the time of hospital or intensive care
unit admission. Infect. Control. Hosp. Epidemiol. 34, 161–170. doi: 10.1086/6
69095
Frontiers in Microbiology | www.frontiersin.org 7 January 2016 | Volume 7 | Article 31
Rondeau et al. Current Epidemiology of MRSA in French Elderly
Milstone, A. M., Passaretti, C. L., and Perl, T. M. (2008). Chlorhexidine: expanding
the armamentarium for infection control and prevention. Clin. Infect. Dis. 46,
274–281. doi: 10.1086/524736
Murchan, S., Kaufmann, M. E., Deplano, A., de Ryck, R., Struelens, M., Zinn, C. E.,
et al. (2003). Harmonization of pulsed-ﬁeld gel electrophoresis protocols for
epidemiological typing of strains of methicillin-reistant Staphylococcus aureus:
a single approach developed by consensus in 10 European laboratories and
its application for tracing the spread of related strains. J. Clin. Microbiol. 41,
1574–1585.
Otter, J. A., Patel, A., Cliﬀ, P. R., Halligan, E. P., Tosas, O., and Edgeworth, J. D.
(2013). Selection for qacA carriage in CC22, but not CC30, methicillin-resistant
Staphylococcus aureus bloodstream infection isolates during a successful
institutional infection control programme. J. Antimicrob. Chemother. 68, 992–
999. doi: 10.1093/jac/dks500
Poole, K. (2005). Eﬄux-mediated antimicrobial resistance. J. Antimicrob.
Chemother. 56, 20–51. doi: 10.1093/jac/dki171
Popovich, K. J., Weinstein, R. A., and Hota, B. (2008). Are community-associated
methicillin-reistant Staphylococcus aureus (MRSA) strains replacing traditional
nosocomial MRSA strains ? Clin. Infect. Dis. 46, 787–794. doi: 10.1086/5
28716
Robert, J., Tristan, A., Cavalié, L., Decousser, J. W., Bes, M., Etienne, J., et al.
(2011). Panton-valentine leukocidin-positive and toxic shock syndrome toxin
1-positive methicillin-resistant Staphylococcus aureus: a French multicenter
propective study in 2008. Antimicrob. Agents Chemother. 55, 1734–1739. doi:
10.1128/AAC.01221-10
Robinson, D. A., and Enright, M. C. (2003). Evolutionary models of the emergence
of methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother.
47, 3926–3934. doi: 10.1128/AAC.47.12.3926-3934.2003
Rolain, J. M., Abat, C., Brouqui, P., and Raoult, D. (2015). Worldwide
decrease in methicillin-resistant Staphylococcus aureus: do we understand
something? Clin. Microbiol. Infect. 21, 515–517. doi: 10.1016/j.cmi.2015.
04.017
Safdar, N., and Bradley, E. A. (2008). the risk of infection after nasal
colonization with Staphylococcus aureus. Am. J. Med. 121, 310–315. doi:
10.1016/j.amjmed.2007.07.034
Suwantarat, N., Carroll, K. C., Tekle, T., Ross, T., Maragakis, L. L.,
Cosgrove, S. E., et al. (2014). High prevalence of reduced chlorhexidine
susceptibility in organisms causing central line-associated bloodstream
infections. Infect. Control Hosp. Epidemiol. 35, 1183–1186. doi: 10.1086/6
77628
Tenover, F. C., and Goering, R. V. (2009). Methicillin-resistant Staphylococcus
aureus strain USA300: origin and epidemiology. J. Antimicrob. Chemother. 64,
441–446. doi: 10.1093/jac/dkp241
van der Mee-Marquet, N., Epinette, C., Loyau, J., Arnault, L., Domelier, A. S.,
Losfelt, B., et al. (2007). Staphylococcus aureus strains isolated from bloodstream
infections changes signiﬁcantly in 2006. J. Clin. Microbiol. 45, 851–857. doi:
10.1128/JCM.02178-06
Warnke, P., Frickmann, H., and Podbielski, A. (2014). Nasal screening
for MRSA: diﬀerent swabs—diﬀerent results! PLoS ONE 9:e111627. doi:
10.1371/journal.pone.0111627
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or ﬁnancial relationships that could
be construed as a potential conﬂict of interest.
Copyright © 2016 Rondeau, Chevet, Blanc, Gbaguidi-Haore, Decalonne, Dos Santos,
Quentin and van der Mee-Marquet on behalf of the Infection Control Régional
Working Group of the Réseau des Hygiénistes du Centre. This is an open-access
article distributed under the terms of the Creative Commons Attribution License
(CC BY). The use, distribution or reproduction in other forums is permitted,
provided the original author(s) or licensor are credited and that the original
publication in this journal is cited, in accordance with accepted academic practice.
No use, distribution or reproduction is permitted which does not comply with these
terms.
Frontiers in Microbiology | www.frontiersin.org 8 January 2016 | Volume 7 | Article 31
